iMedicalApps: Study Shows Promise of Using AI Enabled App for Medication Adherence in Stroke Patients

iMedicalApps, May 16, 2017

Adherence to medications is a major factor in determining patient outcomes. Stroke patients on direct oral anticoagulants (DOACs) are perfect examples of this adherence issue. Regular adherence to their DOACs is essential to prevent the risk of stroke and bleeding. Previously, we have looked into other creative solutions to improve adherence, including ingestible sensors. This time, we are looking at the concept of directly observed therapy that no longer relies on healthcare professionals reviewing patient videos, but has built-in artificial intelligence (AI) capabilities.

In a 12-week, randomized, parallel-group study, Labovitz et al tested the effect of an AI-enabled app, AiCure, on medication adherence in 28 ischemic stroke patients (20 patients were on DOACs including dabigatran, rivaroxaban, and apixaban; 8 were  on warfarin). Not only can AiCure provide patients with reminders and dosing information, it is also capable of carrying out directly observed therapy through HIPAA-compliant facial recognition, automatic medication identification, and real-time medication ingestion confirmation using a smartphone. Read more here.

MobiHealthNews: Study: Texting to Improve Medication Adherence in HIV Patients Shows High Engagement

By: Heather Mack, MobiHealthNews, May 16, 2017

Improving medication adherence is on the wish list of many healthcare stakeholders. Given the multitude of reasons why people don’t stick with their prescriptions, there isn’t just one successful modality to improve their adherence.

But a small study suggests using text messages to engage in two-way communication with patients could be more effective than coming at them with a fully developed tool based on the idea that they are simply forgetting. Moreover, it could lead to a more nuanced understanding of exactly why each individual isn’t taking their medication, thereby informing personalized adherence efforts as well as valuable drug efficacy and safety data. Read more here.